Clover Health Investments (CLOV) Gross Margin (2020 - 2026)

Clover Health Investments has reported Gross Margin for 7 years, with the latest figure at 20.77% in Q1 2026.

• For the quarter ending Q1 2026, Gross Margin fell 279.0% year-over-year to 20.77%; the trailing twelve-month figure through Mar 2026 stood at 18.13% (down 823.0% YoY), and the FY2025 full-year result was 17.09%, down 951.0% from the prior year.
• Gross Margin for Q1 2026 stood at 20.77%, up from 14.9% in the prior quarter.
• The five-year high for Gross Margin was 30.29% in Q2 2024, with the low at 219.84% in Q2 2022.
• Historically, Gross Margin has averaged 9.06% across 5 years, with a median of 20.77% in 2026.
• Annual changes were most pronounced in 2022 — Gross Margin plunged 20868 bps — and 2023, when it surged 24214 bps.
• Clover Health Investments' Gross Margin stood at 4.97% in 2022, then jumped by 503 bps to 20.05% in 2023, then jumped by 39 bps to 27.87% in 2024, then tumbled by 47 bps to 14.9% in 2025, then surged by 39 bps to 20.77% in 2026.
• The last three Gross Margin figures came in at 20.77% (Q1 2026), 14.9% (Q4 2025), and 14.73% (Q3 2025), per Business Quant data.